Merck (MRK) Dividends Paid - Common (2009 - 2026)
Merck's (MRK) quarterly Dividends Paid - Common came in at $2.1 billion in Q2 2026, up 3.23% year-over-year from $2.1 billion in Q2 2025, and up 1.85% quarter-over-quarter from $2.1 billion in Q1 2026.
Analysis
Merck (MRK) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Dividends Paid - Common for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Dividends Paid - Common rose 3.23% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $8.3 billion, a 3.32% increase from a year earlier, with the FY2025 full-year figure at $8.2 billion, up 4.29% from the prior year.
- Dividends Paid - Common was $2.1 billion for Q2 2026 at Merck, up from $2.1 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $2.1 billion in Q2 2026 and troughed at $1.7 billion in Q1 2022.
- A 5-year average of $1.9 billion and a median of $2.0 billion in 2024 frame the typical range for Dividends Paid - Common.
- Across the five-year window, Dividends Paid - Common gained 6.51% in 2022 and rose 2.68% in 2026, its largest moves.
- Over 5 years, Dividends Paid - Common stood at $1.8 billion in 2022, then climbed by 5.83% to $1.9 billion in 2023, then grew by 5.35% to $2.0 billion in 2024, then increased by 3.43% to $2.0 billion in 2025, then gained by 6.24% to $2.1 billion in 2026.
- The last three Dividends Paid - Common figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 1.29 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 6.09 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14 Bn |
| Mar 31, 2026 | 2.11 Bn |
| Dec 31, 2025 | 2.02 Bn |
| Sep 30, 2025 | 2.03 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 2.05 Bn |
| Dec 31, 2024 | 1.95 Bn |
| Sep 30, 2024 | 1.95 Bn |
| Jun 30, 2024 | 1.99 Bn |
| Mar 31, 2024 | 1.95 Bn |
| Dec 31, 2023 | 1.85 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.89 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.75 Bn |
| Sep 30, 2022 | 1.75 Bn |
| Jun 30, 2022 | 1.77 Bn |
| Mar 31, 2022 | 1.75 Bn |
| Dec 31, 2021 | 1.64 Bn |
| Sep 30, 2021 | 1.65 Bn |